Century Therapeutics (IPSC) Operating Expenses (2020 - 2026)
Century Therapeutics (IPSC) posted quarterly Operating Expenses of $23.7 million for Q1 2026, down 32.31% year-over-year from $35.0 million in Q1 2025, and up 14.69% quarter-over-quarter from $20.7 million in Q4 2025.
Century Therapeutics (IPSC) Operating Expenses (2020 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has reported Operating Expenses for 7 consecutive years, with $23.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses fell 32.31% year-over-year to $23.7 million; the TTM figure through Mar 2026 stood at $115.1 million (down 21.98% YoY), while the FY2025 annual figure was $126.4 million, down 12.64% from the prior year.
- Operating Expenses improved to $23.7 million in Q1 2026 per IPSC's latest filing, from $20.7 million in the prior quarter.
- Across five years, Operating Expenses topped out at $44.0 million in Q4 2023 and bottomed at $20.7 million in Q4 2025.
- Historically, Operating Expenses has averaged $34.3 million across 5 years, with a median of $35.0 million in 2025.
- Annual changes were most pronounced in 2022 — Operating Expenses soared 113.12% — and 2025, when it slumped 50.19%.
- Century Therapeutics' Operating Expenses stood at $33.8 million in 2022, then jumped by 30.16% to $44.0 million in 2023, then dropped by 5.84% to $41.5 million in 2024, then plunged by 50.19% to $20.7 million in 2025, then increased by 14.69% to $23.7 million in 2026.
- Business Quant data shows IPSC's Operating Expenses at $23.7 million in Q1 2026, $20.7 million in Q4 2025, and $36.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Century Therapeutics | 346.65 Mn | 86.58 Mn | - | 36.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 36.53 Mn |
| Mar 31, 2026 | 23.68 Mn |
| Dec 31, 2025 | 20.65 Mn |
| Sep 30, 2025 | 36.12 Mn |
| Jun 30, 2025 | 34.66 Mn |
| Mar 31, 2025 | 34.99 Mn |
| Dec 31, 2024 | 41.46 Mn |
| Sep 30, 2024 | 35.58 Mn |
| Jun 30, 2024 | 35.53 Mn |
| Mar 31, 2024 | 32.16 Mn |
| Dec 31, 2023 | 44.03 Mn |
| Sep 30, 2023 | 35.77 Mn |
| Jun 30, 2023 | 35.18 Mn |
| Mar 31, 2023 | 33.80 Mn |
| Dec 31, 2022 | 33.83 Mn |
| Sep 30, 2022 | 33.96 Mn |
| Jun 30, 2022 | 32.75 Mn |
| Mar 31, 2022 | 38.49 Mn |
| Dec 31, 2021 | 27.97 Mn |
| Sep 30, 2021 | 25.83 Mn |